Hla ligand database utilizing predictive algorithms and methods of making and using same
CA 2440740 A1 · Owner: Hickman, Heather D. · Inventors: Hickman, Heather D.; Prilliman, Kiley Rae; Hildebrand, William H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention generally relates to a MHC ligand database populated with MHC ligand sequences, motifs extended motifs subm otifs, ligands unique , to infected cells tumor specific ligands, as well as a collection of current and future developed MHC lignad sequences developed by alternative methods. Other than the ligand sequences developed by alternative methods (which are in many cases non-standarized), the remaining ligand sequences are obtained in a standardized and minimum-variable dependent manner from soluble HLA molecules constructed according to the methodology described herein. The present invention further includes methodologies incorporating linear and predicitve …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 21, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 21, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 21, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.